Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10975139 Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

Patent 10975139 was granted and assigned to Regeneron Pharmaceuticals on April, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11999777 Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+276 characters)
Article

Patent abstract

The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).

Edits on 9 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2023
Edits made to:
Infobox (+13 properties)
Infobox
Patent Inventor Names
Alina Baum0
Andrew Murphy0
Christos Kyratsous0
Cindy Gerson0
Gang Chen0
George D. Yancopoulos0
Johanna Hansen0
Marine Malbec0
Neil Stahl0
Robert Babb0
Tammy Huang0
Wen-Yi Lee0
William Olson0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109751390
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109751390
Date of Patent
April 13, 2021
0
Patent Application Number
169962970
Date Filed
August 18, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109751390
Patent Citations
‌
US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
0
Patent Citations Received
‌
US Patent 11440952 Compositions for preventing or treating viral and other microbial infections
0
Patent Primary Examiner
‌
Benjamin P Blumel
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 19 Sep, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11440952 Compositions for preventing or treating viral and other microbial infections
0
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10975139
Edits on 11 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 11 Feb, 2022
Edits made to:
Infobox (+10 properties)
‌

 US Patent 10975139 Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

Infobox
Is a
Patent
Patent
Patent applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Current assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10975139
Date of patent
April 13, 2021
Patent application number
16996297
Date Filed
August 18, 2020
Patent citations
‌
US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
Patent primary examiner
‌
Benjamin P Blumel

Find more entities like US Patent 10975139 Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo